Lymphangiogenic factors, mechanisms, and applications.
Identifieur interne : 001646 ( PubMed/Curation ); précédent : 001645; suivant : 001647Lymphangiogenic factors, mechanisms, and applications.
Auteurs : Wei Zheng ; Aleksanteri Aspelund ; Kari AlitaloSource :
- The Journal of clinical investigation [ 1558-8238 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Antinéoplasiques.
- physiologie : Protéines angiogéniques.
- physiopathologie : Tumeurs, Vaisseaux lymphatiques.
- traitement médicamenteux : Tumeurs.
- Animaux, Humains, Lymphangiogenèse, Thérapie moléculaire ciblée, Transduction du signal.
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Antineoplastic Agents.
- chemical , physiology : Angiogenic Proteins.
- drug effects : Lymphangiogenesis.
- drug therapy : Neoplasms.
- physiopathology : Lymphatic Vessels, Neoplasms.
- Animals, Humans, Molecular Targeted Therapy, Signal Transduction.
Abstract
Lymphangiogenesis, the growth of lymphatic vessels, is essential in embryonic development. In adults, it is involved in many pathological processes such as lymphedema, inflammatory diseases, and tumor metastasis. Advances during the past decade have dramatically increased the knowledge of the mechanisms of lymphangiogenesis, including the roles of transcription factors, lymphangiogenic growth factors and their receptors, and intercellular and intracellular signaling cascades. Strategies based on these mechanisms are being tested in the treatment of various human diseases such as cancer, lymphedema, and tissue allograft rejection. This Review summarizes the recent progress on lymphangiogenic mechanisms and their applications in disease treatment.
DOI: 10.1172/JCI71603
PubMed: 24590272
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001646
Links to Exploration step
pubmed:24590272Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphangiogenic factors, mechanisms, and applications.</title><author><name sortKey="Zheng, Wei" sort="Zheng, Wei" uniqKey="Zheng W" first="Wei" last="Zheng">Wei Zheng</name></author><author><name sortKey="Aspelund, Aleksanteri" sort="Aspelund, Aleksanteri" uniqKey="Aspelund A" first="Aleksanteri" last="Aspelund">Aleksanteri Aspelund</name></author><author><name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24590272</idno><idno type="pmid">24590272</idno><idno type="doi">10.1172/JCI71603</idno><idno type="wicri:Area/PubMed/Corpus">001646</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001646</idno><idno type="wicri:Area/PubMed/Curation">001646</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001646</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphangiogenic factors, mechanisms, and applications.</title><author><name sortKey="Zheng, Wei" sort="Zheng, Wei" uniqKey="Zheng W" first="Wei" last="Zheng">Wei Zheng</name></author><author><name sortKey="Aspelund, Aleksanteri" sort="Aspelund, Aleksanteri" uniqKey="Aspelund A" first="Aleksanteri" last="Aspelund">Aleksanteri Aspelund</name></author><author><name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name></author></analytic><series><title level="j">The Journal of clinical investigation</title><idno type="eISSN">1558-8238</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Angiogenic Proteins (physiology)</term><term>Animals</term><term>Antineoplastic Agents (pharmacology)</term><term>Humans</term><term>Lymphangiogenesis (drug effects)</term><term>Lymphatic Vessels (physiopathology)</term><term>Molecular Targeted Therapy</term><term>Neoplasms (drug therapy)</term><term>Neoplasms (physiopathology)</term><term>Signal Transduction</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antinéoplasiques (pharmacologie)</term><term>Humains</term><term>Lymphangiogenèse ()</term><term>Protéines angiogéniques (physiologie)</term><term>Thérapie moléculaire ciblée</term><term>Transduction du signal</term><term>Tumeurs (physiopathologie)</term><term>Tumeurs (traitement médicamenteux)</term><term>Vaisseaux lymphatiques (physiopathologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Angiogenic Proteins</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Lymphangiogenesis</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Protéines angiogéniques</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Tumeurs</term><term>Vaisseaux lymphatiques</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphatic Vessels</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Molecular Targeted Therapy</term><term>Signal Transduction</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Humains</term><term>Lymphangiogenèse</term><term>Thérapie moléculaire ciblée</term><term>Transduction du signal</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphangiogenesis, the growth of lymphatic vessels, is essential in embryonic development. In adults, it is involved in many pathological processes such as lymphedema, inflammatory diseases, and tumor metastasis. Advances during the past decade have dramatically increased the knowledge of the mechanisms of lymphangiogenesis, including the roles of transcription factors, lymphangiogenic growth factors and their receptors, and intercellular and intracellular signaling cascades. Strategies based on these mechanisms are being tested in the treatment of various human diseases such as cancer, lymphedema, and tissue allograft rejection. This Review summarizes the recent progress on lymphangiogenic mechanisms and their applications in disease treatment.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24590272</PMID><DateCreated><Year>2014</Year><Month>03</Month><Day>04</Day></DateCreated><DateCompleted><Year>2014</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>124</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J. Clin. Invest.</ISOAbbreviation></Journal><ArticleTitle>Lymphangiogenic factors, mechanisms, and applications.</ArticleTitle><Pagination><MedlinePgn>878-87</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI71603</ELocationID><ELocationID EIdType="pii" ValidYN="Y">71603</ELocationID><Abstract><AbstractText>Lymphangiogenesis, the growth of lymphatic vessels, is essential in embryonic development. In adults, it is involved in many pathological processes such as lymphedema, inflammatory diseases, and tumor metastasis. Advances during the past decade have dramatically increased the knowledge of the mechanisms of lymphangiogenesis, including the roles of transcription factors, lymphangiogenic growth factors and their receptors, and intercellular and intracellular signaling cascades. Strategies based on these mechanisms are being tested in the treatment of various human diseases such as cancer, lymphedema, and tissue allograft rejection. This Review summarizes the recent progress on lymphangiogenic mechanisms and their applications in disease treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Aspelund</LastName><ForeName>Aleksanteri</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Alitalo</LastName><ForeName>Kari</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ERC_268804</GrantID><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042501">Angiogenic Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2007 Jul;43(11):1748-54</RefSource><PMID Version="1">17570654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2012 Oct 1;18(19):5387-98</RefSource><PMID Version="1">22932666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2003 Mar;111(5):717-25</RefSource><PMID Version="1">12618526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2008 May 1;78(2):315-23</RefSource><PMID Version="1">18065770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2012 Dec;103(12):2144-52</RefSource><PMID Version="1">22937829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Jul 28;118(4):1154-62</RefSource><PMID Version="1">21566091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2013 Mar 6;32(5):629-44</RefSource><PMID Version="1">23299940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Jun 25;141(7):1117-34</RefSource><PMID Version="1">20602996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Sep 15;68(18):7342-51</RefSource><PMID Version="1">18794121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2008 Jul 15;319(2):309-20</RefSource><PMID Version="1">18514180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15491-6</RefSource><PMID Version="1">17030814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2007 May;98(5):726-33</RefSource><PMID Version="1">17425689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasia. 2013 Feb;15(2):112-24</RefSource><PMID Version="1">23441126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2012 Mar 21;104(6):461-75</RefSource><PMID Version="1">22343031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ J. 2009 Dec;73(12):2183-91</RefSource><PMID Version="1">19838001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2013 May 7;17(5):671-84</RefSource><PMID Version="1">23663736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(6):e39558</RefSource><PMID Version="1">22745786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2012 Aug 3;111(4):426-36</RefSource><PMID Version="1">22723300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):401-7</RefSource><PMID Version="1">19112163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2004 Apr;95(4):328-33</RefSource><PMID Version="1">15072591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2002 Sep 16;196(6):719-30</RefSource><PMID Version="1">12235206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2011;17(11):1371-80</RefSource><PMID Version="1">22064427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Sep 3;20(17):4762-73</RefSource><PMID Version="1">11532940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2011 Aug 19;109(5):486-91</RefSource><PMID Version="1">21778431</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2009 May 28;113(22):5650-9</RefSource><PMID Version="1">19346498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2007 Jun 1;129(5):957-68</RefSource><PMID Version="1">17540175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15894-9</RefSource><PMID Version="1">22967508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2011 Jan 28;34(1):96-107</RefSource><PMID Version="1">21256057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2665-74</RefSource><PMID Version="1">22949700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e40497</RefSource><PMID Version="1">22792354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):564-70</RefSource><PMID Version="1">17194894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2011 May;31(5):1049-58</RefSource><PMID Version="1">21311040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2005 Jun 15;105(12):4649-56</RefSource><PMID Version="1">15705793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Jan 1;69(1):349-57</RefSource><PMID Version="1">19118020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2011 Feb 9;3(69):69ra11</RefSource><PMID Version="1">21307301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2006 Mar 1;66(5):2650-7</RefSource><PMID Version="1">16510584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2012 Feb 14;21(2):181-95</RefSource><PMID Version="1">22340592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2012 May;40(5):1321-30</RefSource><PMID Version="1">22327175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2009 Oct;238(10):2670-9</RefSource><PMID Version="1">19705443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Med. 2013 Jan;3(1):a006569</RefSource><PMID Version="1">23085847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2013 Apr;182(4):1434-47</RefSource><PMID Version="1">23391392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2010 Jan 18;207(1):17-27</RefSource><PMID Version="1">20026661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Jan 5;97(1):14-21</RefSource><PMID Version="1">15632376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 Nov 21;122(22):3666-77</RefSource><PMID Version="1">24113869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(9):e74686</RefSource><PMID Version="1">24023956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2013 Apr;123(4):1571-9</RefSource><PMID Version="1">23524964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Jun 1;65(11):4739-46</RefSource><PMID Version="1">15930292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2008 Jul;173(1):265-77</RefSource><PMID Version="1">18535184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Dec 15;70(24):10411-21</RefSource><PMID Version="1">21056990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12677-82</RefSource><PMID Version="1">11592985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 Feb 14;121(7):1229-37</RefSource><PMID Version="1">23264596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2002 Oct;129(20):4797-806</RefSource><PMID Version="1">12361971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2009 Dec;41(12):1272-4</RefSource><PMID Version="1">19935664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Jan 20;117(3):1081-90</RefSource><PMID Version="1">20705758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):658-64</RefSource><PMID Version="1">18174461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Apr 28;117(17):4667-78</RefSource><PMID Version="1">21364190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2010 Dec;177(6):3233-43</RefSource><PMID Version="1">20952594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(7):e68755</RefSource><PMID Version="1">23874750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 May 27;465(7297):483-6</RefSource><PMID Version="1">20445537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Oct 15;65(20):9261-8</RefSource><PMID Version="1">16230387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2009 Jun;46(6):399-404</RefSource><PMID Version="1">19289394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2013 May;257(5):961-7</RefSource><PMID Version="1">23013803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2010 Mar 30;121(12):1413-22</RefSource><PMID Version="1">20231530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Dec 21;444(7122):1032-7</RefSource><PMID Version="1">17183313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2012 Feb 14;22(2):430-45</RefSource><PMID Version="1">22306086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2008 May 1;111(9):4571-9</RefSource><PMID Version="1">18310502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Retin Eye Res. 2013 May;34:89-124</RefSource><PMID Version="1">23348581</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Physiol Biochem. 2010;26(1):87-96</RefSource><PMID Version="1">20502008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1996 Apr 1;15(7):1751</RefSource><PMID Version="1">8612600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2005 Feb;115(2):247-57</RefSource><PMID Version="1">15668734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2012 Aug 3;111(4):437-45</RefSource><PMID Version="1">22723296</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2009 Sep;15(9):1023-30</RefSource><PMID Version="1">19668192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11658-63</RefSource><PMID Version="1">15289610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 May 31;366(22):2136-7</RefSource><PMID Version="1">22646649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Dec 15;67(24):11528-35</RefSource><PMID Version="1">18089781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2010 Dec;177(6):3202-14</RefSource><PMID Version="1">21056998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2014 Feb;124(2):824-34</RefSource><PMID Version="1">24430181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2002 Jun 5;94(11):819-25</RefSource><PMID Version="1">12048269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Nov 27;326(5957):1220-4</RefSource><PMID Version="1">19965465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1997 May 30;276(5317):1423-5</RefSource><PMID Version="1">9162011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(6):e39540</RefSource><PMID Version="1">22761819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 May 16;121(20):4242-9</RefSource><PMID Version="1">23476047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2007 Jun 11;204(6):1431-40</RefSource><PMID Version="1">17535974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2004 Mar;15(3):603-12</RefSource><PMID Version="1">14978162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2003 Nov;17(14):2006-13</RefSource><PMID Version="1">14597670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2009 Oct;119(10):2954-64</RefSource><PMID Version="1">19759514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2009 Mar;10(3):165-77</RefSource><PMID Version="1">19234476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2013 Jun;140(11):2365-76</RefSource><PMID Version="1">23615281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2007 Dec;13(12):1458-66</RefSource><PMID Version="1">18059280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2009 Dec;136(23):4043-53</RefSource><PMID Version="1">19906871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Feb 25;115(8):1654-61</RefSource><PMID Version="1">19903896</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Apr 3;273(14):8413-8</RefSource><PMID Version="1">9525952</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Dec 21;444(7122):1083-7</RefSource><PMID Version="1">17183323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Jul 15;73(14):4212-21</RefSource><PMID Version="1">23695550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 Jul 25;122(4):598-607</RefSource><PMID Version="1">23741013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Cancer Res. 2012;114:59-85</RefSource><PMID Version="1">22588056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1695-702</RefSource><PMID Version="1">20466977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasia. 2012 Mar;14(3):228-37</RefSource><PMID Version="1">22496622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2014 Jan 3;114(1):56-66</RefSource><PMID Version="1">24122719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2010 Feb;10(2):116-29</RefSource><PMID Version="1">20094046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2000 Jun;25(2):153-9</RefSource><PMID Version="1">10835628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2011 May 9;208(5):1083-92</RefSource><PMID Version="1">21536744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2007 Nov;117(11):3369-82</RefSource><PMID Version="1">17948123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2008 Apr;13(4):331-42</RefSource><PMID Version="1">18394556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2010 Dec 14;18(6):630-40</RefSource><PMID Version="1">21130043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2012 Nov;181(5):1607-20</RefSource><PMID Version="1">22959907</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2003 May 30;92(10):1098-106</RefSource><PMID Version="1">12714562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2004 Apr;113(7):1040-50</RefSource><PMID Version="1">15057311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 May 10;119(19):4565-76</RefSource><PMID Version="1">22446484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2013 Jan;27(1):76-85</RefSource><PMID Version="1">22997228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2011 Feb 15;123(6):613-20</RefSource><PMID Version="1">21282502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2001 Feb;7(2):199-205</RefSource><PMID Version="1">11175851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2011;10:36</RefSource><PMID Version="1">21481239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2013 May;140(9):1857-70</RefSource><PMID Version="1">23571211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2008 Aug 15;112(4):1129-38</RefSource><PMID Version="1">18541717</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2012 Jan;22(1):23-32</RefSource><PMID Version="1">22157652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Immunol. 2012 Jul;33(7):350-6</RefSource><PMID Version="1">22579522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2113-27</RefSource><PMID Version="1">18849330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2010 Jan 11;188(1):115-30</RefSource><PMID Version="1">20065093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2013 Mar 15;112(6):956-60</RefSource><PMID Version="1">23410910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 2013 May 15;319(9):1281-8</RefSource><PMID Version="1">23328307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2009 Mar 12;113(11):2605-13</RefSource><PMID Version="1">19098273</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6223-8</RefSource><PMID Version="1">22474390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2011 May 16;193(4):607-18</RefSource><PMID Version="1">21576390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2011 Nov 15;71(22):7103-12</RefSource><PMID Version="1">21975930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Aug 1;65(15):6901-9</RefSource><PMID Version="1">16061674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Jun 15;68(12):4754-62</RefSource><PMID Version="1">18559522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Jul 29;116(4):512-3</RefSource><PMID Version="1">20671134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Oct 17;278(42):40973-9</RefSource><PMID Version="1">12881528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566-70</RefSource><PMID Version="1">7724599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2004 Jan;5(1):74-80</RefSource><PMID Version="1">14634646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2011 Apr 12;19(4):512-26</RefSource><PMID Version="1">21481792</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2012 Feb 1;72(3):726-35</RefSource><PMID Version="1">22298596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2012 Aug;11(8):1637-49</RefSource><PMID Version="1">22584122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2002 Sep;3(3):411-23</RefSource><PMID Version="1">12361603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2006 Oct;70(4):330-5</RefSource><PMID Version="1">16965327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Mar 15;20(6):1223-31</RefSource><PMID Version="1">11250889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Jul 1;115(26):5418-26</RefSource><PMID Version="1">20407033</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Feb 19;140(4):460-76</RefSource><PMID Version="1">20178740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cardiovasc Med. 2010 Nov;20(8):249-53</RefSource><PMID Version="1">22433650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2005 Feb 1;19(3):397-410</RefSource><PMID Version="1">15687262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2009 Apr;41(4):396-8</RefSource><PMID Version="1">19287381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 2001 Nov;109(1):115-9</RefSource><PMID Version="1">11677062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2010 Sep 27;207(10):2255-69</RefSource><PMID Version="1">20837699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2005 Jun 15;105(12):4642-8</RefSource><PMID Version="1">15746084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2013 Jan;34(1):23-31</RefSource><PMID Version="1">23074044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2006 Jul;20(9):1462-72</RefSource><PMID Version="1">16816121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2005 Apr 4;201(7):1089-99</RefSource><PMID Version="1">15809353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8868-73</RefSource><PMID Version="1">12070340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2006 Feb;12(2):235-9</RefSource><PMID Version="1">16462802</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D042501" MajorTopicYN="N">Angiogenic Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042583" MajorTopicYN="N">Lymphangiogenesis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3934166</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24590272</ArticleId><ArticleId IdType="pii">71603</ArticleId><ArticleId IdType="doi">10.1172/JCI71603</ArticleId><ArticleId IdType="pmc">PMC3934166</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001646 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001646 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24590272
|texte= Lymphangiogenic factors, mechanisms, and applications.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24590272" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |